Maker Of Oxycontin Drug Negotiating Settlement Of Over 2000 Lawsuits For $12 Billion
Prescription opioids have played a major role in the nationwide opioid crisis, and litigation involving Purdue Pharma and other companies has resulted in billions of dollars being directed toward treatment, prevention, recovery, and other opioid-abatement efforts.
The opioid crisis has affected communities throughout the United States, including families and communities throughout Central Illinois. Prescription opioid medications can provide legitimate medical benefits when appropriately prescribed and used, but opioids also carry significant risks, including dependence, addiction, overdose, and death.
Those risks have led to extensive litigation against pharmaceutical manufacturers, distributors, pharmacies, marketing companies, and other entities accused of contributing to the opioid crisis. One of the most prominent cases involves Purdue Pharma, the manufacturer of OxyContin, and members of the Sackler family who owned and controlled the company.
Important Update: The Purdue Pharma and Sackler settlement is substantially different from the earlier $10 billion to $12 billion proposal described in older versions of this article. In June 2025, a $7.4 billion settlement was reached with Purdue and the Sackler family, and the settlement became legally effective in May 2026. Illinois and local governments are expected to receive approximately $148.8 million in opioid-abatement funds over 15 years.
What Happened With Purdue Pharma and the Opioid Crisis?
Purdue Pharma manufactured and marketed OxyContin, an extended-release prescription opioid. Purdue became a central defendant in litigation concerning the opioid epidemic, with governments, individuals, and other parties pursuing claims relating to the company’s marketing and distribution of opioid medications.
The U.S. Supreme Court’s 2024 decision in Harrington v. Purdue Pharma L.P. described Purdue as being at the center of the prescription-opioid crisis and noted that Purdue had been owned and controlled by members of the Sackler family. The Court’s opinion also discussed Purdue’s 2007 federal guilty plea involving the misbranding of OxyContin as a less-addictive and less-abusable medication.
Federal prosecutors separately brought criminal charges against Purdue. In 2020, Purdue pleaded guilty to federal felony offenses involving conspiracy to defraud the United States, violations of the Food, Drug, and Cosmetic Act, and conspiracy to violate the federal Anti-Kickback Statute.
Those criminal proceedings are separate from the civil litigation brought by states, local governments, individuals, and other parties concerning the opioid crisis.
The Purdue Settlement Has Changed Over Time
The Purdue litigation has involved several proposed resolutions over a period of years. An older version of this article described a proposed settlement of approximately $10 billion to $12 billion, including a proposed contribution of $3 billion from members of the Sackler family.
That is no longer the current settlement structure.
2020 Resolution
Purdue reached a federal criminal and civil resolution involving more than $8 billion in potential value, subject to bankruptcy proceedings and other conditions. The proposed structure contemplated transforming Purdue into a public benefit company.
2024 Supreme Court Decision
The Supreme Court rejected the bankruptcy plan’s proposed releases of claims against the Sackler family and sent the case back for further proceedings.
2025 Settlement
A new $7.4 billion settlement was reached with Purdue and the Sackler family, with the Sacklers losing control of Purdue and being barred from selling opioids in the United States.
2026 Effective Date
The settlement became legally effective in May 2026. Illinois and local governments are expected to receive approximately $148.8 million for opioid-abatement efforts over 15 years.
What Does the Current Purdue Settlement Provide?
The current settlement reached by a coalition of state attorneys general and other parties provides approximately $7.4 billion in total value from Purdue Pharma and members of the Sackler family.
The settlement ends the Sackler family’s control of Purdue and permanently bars the family from selling opioids in the United States. Settlement funds are being directed toward communities and programs addressing opioid addiction, prevention, treatment, and recovery.
Illinois’ Share
The Illinois Attorney General’s Office announced in May 2026 that Illinois and the state’s local governments are expected to receive approximately $148.8 million in abatement funds from the Purdue settlement over the next 15 years. Most of the settlement funds are scheduled to be distributed during the first three years.
The funds are intended to help address the continuing effects of opioid addiction through treatment, prevention, recovery, and other opioid-abatement programs. The settlement is therefore not simply a payment to one government entity; it is structured to direct resources toward communities affected by the opioid crisis.
What Happened to the Sackler Family’s Ownership of Purdue?
One of the important terms of the current settlement is the end of the Sackler family’s control of Purdue.
The Illinois Attorney General’s Office states that the settlement permanently bars the Sackler family from selling opioids in the United States and ends the family’s control of Purdue.
This provision is significant because the Sackler family had owned and controlled Purdue during the period in which the company manufactured and marketed OxyContin.
A Legal Distinction: The settlement’s terms concerning Purdue and the Sackler family should not be confused with a finding that every individual opioid-related injury claim has been resolved. Government settlements, bankruptcy proceedings, and individual personal-injury claims can involve different parties, procedures, rights, and deadlines.
Purdue’s Public Benefit Company Structure
An important concept in the Purdue bankruptcy proceedings has been the possibility of restructuring Purdue so that its assets and future operations serve public-health purposes rather than returning the company to its former ownership structure.
The Department of Justice’s earlier resolution required Purdue to cease operating in its existing form and contemplated its emergence as a public benefit company or similar entity designed to benefit the public. The proposed structure included directing proceeds toward state and local opioid-abatement programs and providing or donating certain medications, including overdose-rescue and medication-assisted-treatment products, to communities.
The current 2026 federal criminal resolution also provides for a potential public benefit company structure. The Department of Justice reported that Purdue was ordered to pay a $3.544 billion criminal fine and $2 billion in criminal forfeiture, with up to $1.775 billion of the forfeiture potentially credited based on value provided through a public-benefit-company structure.
Why Opioid Litigation Matters to Central Illinois
The opioid crisis is not limited to large metropolitan areas. Families throughout Illinois have experienced addiction, overdose, disability, medical expenses, lost income, and deaths associated with opioid use.
Settlement funds are intended in part to provide resources for communities dealing with these consequences. The Illinois Attorney General’s Office has stated that Illinois’ Purdue settlement funds will be used to address the impact of opioid addiction throughout the state.
Treatment
Funding can support programs designed to help people obtain treatment for opioid-use disorders.
Prevention
Communities can use opioid-abatement resources for prevention and education programs.
Recovery
Recovery services can provide continuing support to individuals and families affected by opioid addiction.
Community Response
Settlement funds can help communities address the broader effects of the opioid crisis and expand available services.
Other Companies Have Also Faced Opioid-Related Litigation
Purdue Pharma is only one company involved in the extensive litigation surrounding the opioid epidemic. Governments have also pursued claims involving manufacturers, distributors, pharmacies, consulting companies, and marketing firms.
For example, the Illinois Attorney General’s Office announced a $350 million national settlement with Publicis Health in 2024 concerning the marketing and communications firm’s alleged role in the prescription-opioid epidemic. Illinois was expected to receive approximately $11.4 million under that settlement if approved.
These cases demonstrate that opioid litigation can involve more than the manufacturer of a particular medication. The specific allegations, defendants, legal theories, and available remedies differ from case to case.
What Is a Dangerous Drug Product Liability Claim?
Product liability law can provide legal remedies when a defective or dangerously marketed product causes injury. Depending on the circumstances, a claim may involve allegations concerning the design of a product, manufacturing defects, inadequate warnings, or other theories recognized under applicable law.
Drug-related product liability cases can be particularly complicated because prescription medications are subject to federal regulation, physicians make prescribing decisions, pharmaceutical companies provide warnings and marketing information, and the medical history of the injured person can be extensive.
Warnings
A claim may examine whether adequate warnings about risks were provided and communicated to the appropriate parties.
Marketing
The marketing and promotion of prescription medications can become relevant in litigation involving allegations of misleading or inappropriate promotion.
Causation
A claimant generally must establish a legally sufficient connection between the alleged wrongful conduct or defective product and the injury claimed.
Damages
Depending on the claim, damages can involve medical expenses, lost income, disability, pain and suffering, and other legally recognized losses.
Not every injury associated with a prescription drug automatically creates a successful product liability claim. These cases require a fact-specific legal and medical analysis.
Evidence Can Be Important in a Dangerous Drug Case
Drug-related injury cases can require substantial documentation. The evidence needed depends on the specific allegations and the type of claim being pursued.
Potentially Important Evidence Includes:
- Prescription and pharmacy records
- Medical records and treatment history
- Documentation of addiction treatment or rehabilitation
- Hospital and emergency-room records
- Information concerning dosage and duration of opioid use
- Medical bills and other financial losses
- Employment and income records
- Information concerning the medication and prescribing physician
- Expert medical and pharmaceutical testimony when appropriate
- Evidence concerning the manufacturer’s warnings, marketing, or other conduct at issue
The Purdue Settlement Does Not Automatically Answer Every Individual Claim
It is important for anyone researching an opioid injury to understand the distinction between a large governmental settlement and an individual’s potential personal injury claim.
The Purdue settlement involves a complex bankruptcy and multi-party resolution. Individual victims, governmental entities, creditors, and other claimants can have different rights and procedures. The Supreme Court’s 2024 decision itself arose from the bankruptcy plan and the proposed release of claims against the Sackler family.
A person who believes that a prescription drug caused an injury should therefore obtain case-specific legal advice rather than assuming that the Purdue settlement automatically provides compensation or resolves the person’s potential claim.
Patel Law and Dangerous Drug Claims
The personal injury attorneys at Patel Law, P.C. represent clients in personal injury matters, including claims involving serious injuries and defective or dangerous products when the facts support a legal claim.
Attorney Baku N. Patel and the Patel Law team understand that serious injuries can affect not only the person who was injured but also spouses, children, and other family members. A dangerous drug case can involve extensive medical records, complicated causation questions, and substantial damages, making a careful investigation important.
Have You Been Injured by a Dangerous Drug?
If you believe a prescription medication caused serious injury, addiction, overdose, or another legally compensable harm, an attorney can review your medical history, the medication involved, the circumstances surrounding its use, and the potential legal claims and deadlines that may apply.
Frequently Asked Questions About Dangerous Drug Claims
Is Purdue Pharma still involved in opioid litigation?
Purdue has been involved in extensive bankruptcy, civil, and criminal proceedings. A $7.4 billion settlement with Purdue and members of the Sackler family became legally effective in May 2026. Separately, Purdue was sentenced in federal court in April 2026 and ordered to pay more than $5 billion in criminal penalties.
How much will Illinois receive from the Purdue settlement?
The Illinois Attorney General’s Office estimates that Illinois and local governments will receive approximately $148.8 million in abatement funds over 15 years.
Does the Purdue settlement automatically compensate every person injured by OxyContin?
No. The settlement is a complex multi-party resolution involving Purdue, the Sackler family, governmental entities, creditors, and other claimants. Whether an individual has a separate claim, is eligible for a particular recovery, or has a viable product liability action depends on the circumstances and applicable legal procedures.
Can a prescription drug company be sued for injuries caused by a medication?
Potentially. Prescription-drug litigation can involve product liability, failure-to-warn, negligence, consumer-protection, or other legal theories depending on the facts and applicable law. A successful claim requires the claimant to satisfy the legal requirements applicable to the particular theory.
What should I do if I believe a dangerous drug injured me?
Continue following appropriate medical advice, preserve relevant prescription and medical records, document your treatment and losses, and speak with an attorney about the potential legal claims and deadlines that may apply. Avoid assuming that participation in one opioid settlement means every potential claim is covered.
Sources and Illinois Opioid Resources
Illinois Attorney General: Illinois’ $7.4 Billion Purdue Opioid Settlement
Illinois Attorney General: 2025 Purdue and Sackler Settlement Announcement
Illinois Attorney General: Illinois Joins $7.4 Billion Purdue Settlement
U.S. Supreme Court: Harrington v. Purdue Pharma L.P.
U.S. Department of Justice: United States v. Purdue Pharma L.P.
U.S. Department of Justice: Purdue Pharma Sentencing and Criminal Penalties
U.S. Department of Justice: 2020 Purdue Pharma Global Resolution
Patel Law, P.C.: Contact Patel Law Team
Injured by a Dangerous Drug?
If you believe a prescription medication or other dangerous drug caused serious injury, Patel Law, P.C. can review the circumstances and explain the legal options that may be available.
